|
Microchip Implants Cause Malignant Tumors In Lab Animals |
Posted by Julia
 source The Citizen's Advocate
September 8th, 2007
Dr. Katherine Albrecht
Founder and Director, CASPIAN Consumer Privacy
Damning research could spell the end of VeriChip
The Associated Press will issue a breaking
story this weekend revealing that microchip implants have induced
cancer in laboratory animals and dogs, says privacy expert and
long-time VeriChip opponent Dr. Katherine Albrecht.
As the AP will report, a series of research articles spanning more
than a decade found that mice and rats injected with
glass-encapsulated RFID transponders developed malignant,
fast-growing, lethal cancers in up to 1% to 10% of cases. The
tumors originated in the tissue surrounding the microchips and
often grew to completely surround the devices, the researchers
said.
![]() 
Albrecht first became aware of the microchip-cancer link when she
and her "Spychips" co-author, Liz McIntyre, were contacted by a
pet owner whose dog had died from a chip-induced tumor. Albrecht
then found medical studies showing a causal link between microchip
implants and cancer in other animals. Before she brought the
research to the AP's attention, none of the studies had received
widespread public notice.
A four-month AP investigation turned up additional documents,
several of which had been published before VeriChip's parent
company, Applied Digital Solutions, sought FDA approval to market
the implant for humans. The VeriChip received FDA approval in 2004
under the watch of then Health and Human Services Secretary Tommy
Thompson who later joined the board of the company.
Under FDA policy, it would have been VeriChip's responsibility to
bring the adverse studies to the FDA's attention, but VeriChip CEO
Scott Silverman claims the company was unaware of the research.
Albrecht expressed skepticism that a company like VeriChip, whose
primary business is microchip implants, would be unaware of
relevant studies in the published literature.
"For Mr. Silverman not to know about this research would be
negligent. If he did know about these studies, he certainly had an
incentive to keep them quiet," said Albrecht. "Had the FDA known
about the cancer link, they might never have approved his
company's product."
Since gaining FDA approval, VeriChip has aggressively targeted
diabetic and dementia patients, and recently announced that it had
chipped 90 Alzheimer's patients and their caregivers in Florida.
Employees in the Mexican Attorney General's Office, workers in a
U.S. security firm, and club-goers in Europe have also been
implanted.
Albrecht expressed concern for those who have received a chip
implant, urging them to get the devices removed as soon as
possible.
"These new revelations change everything," she said. "Why would
anyone take the risk of a cancer chip in their arm?"
source The Citizen Advocate
HemuZ Technology
See also:
|
